Allogeneic Gammadelta T Cells Combined With Interferon- α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Conditions: Melanoma Interventions: Biological: Ex-vivo expanded allogeneic γδ T cells; Drug: Recombinant human interferon α1b; Drug: Pembrolizumab Sponsors: Xijing Hospital; Beijing GD Initiative Cell Therapy Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials